5 / 5 Stars
5 5 1 5 1
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
U.S. News evaluated 96 Emerging Markets Bond Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
The fund has returned 2.89 percent over the past year, 11.00 percent over the past three years, 20.64 percent over the past five years, and 11.41 percent over the past decade.
|Trailing Returns||Updated 03.31.2014|
|Year to date||4.1%|
|3 Years (Annualized)||11.0%|
|5 Years (Annualized)||20.6%|
|10 Years (Annualized)||11.4%|
The investment seeks total return in excess of that of its benchmark, the J.P. Morgan EMBI Global. The fund invests primarily in debt of emerging countries that is issued by a sovereign or its instrumentalities outside the country of the issuer and usually is denominated in the currency of the country in which it is issued (e.g., U.S. dollar, Euro, Japanese yen, Swiss franc and British pound sterling). Under normal circumstances, the fund invests directly and indirectly (e.g., through other GMO Funds or derivatives) at least 80% of its assets in debt investments tied economically to emerging countries. It is non-diversified.
Fees are Low compared to funds in the same category.
GMO Emerging Country Debt Fund has an expense ratio of 0.55 percent.
Risk is Above Average compared to funds in the same category according to Morningstar.